[Reference values for 2 well-defined populations: newborn infants and post-partum women]

Clinical Biochemistry
|August 1, 1981
PubMed

Insights

New reference values for newborns and postpartum women show significant differences in 19 SMAC system parameters compared to older children and adults, highlighting distinct physiological states.

Area of Science:

  • Clinical Biochemistry
  • Pediatric Medicine
  • Obstetrics and Gynecology

Context:

  • Establishing accurate reference ranges is crucial for interpreting clinical laboratory results.
  • Previous reference values may not adequately represent the unique physiological states of newborns and postpartum women.
  • The SMAC (Sequential Multiple Analyzer Computer) system is a widely used automated clinical chemistry analyzer.

Purpose:

  • To determine and present reference values for 19 biochemical parameters in four-day-old newborns and postpartum women.
  • To compare these new reference values with those of established populations (1-3-year-old children and 20-39-year-old women).

Summary:

  • Reference values for 19 parameters were measured in newborns and postpartum women using a SMAC system.
  • Newborns exhibited higher values for 8 parameters and lower values for 9 parameters compared to 1-3-year-old children.
  • Postpartum women showed higher values for 7 parameters and lower values for 6 parameters compared to 20-39-year-old women.

Impact:

  • These findings underscore the necessity of distinct reference ranges for newborns and postpartum women for accurate clinical assessment.
  • The data provides essential updated information for clinical laboratories and healthcare providers managing these specific patient populations.
  • Highlights potential differences in metabolic and physiological processes between these groups and the general adult/pediatric populations.

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Guidelines For Measuring Vital Signs01:19

Guidelines For Measuring Vital Signs

Following these guidelines can help nurses accurately measure vital signs, assess changes in patient conditions, and provide timely treatment when necessary. Adhering closely to the guidelines ensures the accuracy and reliability of the results.
Before taking a patient's vital signs, a nurse would consider and assess the patient's comfort level and ensure appropriate equipment is available.
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...